Page 43 | Certara

On-Demand Webinar

RAPS Sponsored Webcast: Optimizing Pediatric Oncology Drug Development: A Comprehensive Overview

Developing safe and effective oncology medications for children presents unique challenges due to ethical considerations…

CertaraOctober 17, 2024

Press Release

Certara Appoints John Reynders as New Independent Board Member

RADNOR, PA., October 16, 2024 — Certara, Inc. (Nasdaq: CERT), a global leader in model-informed…

CertaraOctober 16, 2024

Fact Sheet

Certara University: Grow as a PK/PD Scientist

CertaraOctober 16, 2024

Fact Sheet

Empower Your Students with Industry-Leading Software

CertaraOctober 16, 2024

Fact Sheet

Academic Centers of Excellence for Model-informed Drug Development (MIDD)

CertaraOctober 16, 2024

Publication

Medicines in pregnancy: A clinical pharmacology extrapolation framework to address knowledge gaps

CertaraOctober 16, 2024

Video

Pinnacle 21 Enterprise Data Exchange | How to get more compliant vendor data, delivered faster!

CertaraOctober 11, 2024

Conference

World ADC

CertaraOctober 11, 2024

Announcement

Certara Head of AI Recognized in PharmaVoice 100

Certara’s Senior Vice President, Chris Bouton, Head of Artificial Intelligence recognized for his technical innovation,…

CertaraOctober 10, 2024

White Paper

Clinical Trial Data Sharing Under EMA Policy 0070

CertaraOctober 9, 2024

© 2025 Certara. All Rights Reserved. | Legal | Privacy policy